Published online Apr 7, 2020. doi: 10.3748/wjg.v26.i13.1439
Peer-review started: December 21, 2019
First decision: January 3, 2020
Revised: January 20, 2020
Accepted: March 9, 2020
Article in press: March 9, 2020
Published online: April 7, 2020
Processing time: 108 Days and 14.2 Hours
Lanthanum carbonate is used for treatment of hyperphosphatemia mostly in patients with chronic renal failure. Although lanthanum carbonate is safe, recently, lanthanum deposition in the gastrointestinal mucosa of patients has been reported in the literature. This review provides an overview of gastroduodenal lanthanum deposition and focuses on disease’s endoscopic, radiological, and histological features, prevalence, and outcome, by reviewing relevant clinical studies, case reports, and basic research findings, to better understand the endoscopic manifestation of gastrointestinal lanthanum deposition. The possible relationship between gastric lanthanum deposition pattern and gastric mucosal atrophy is also illustrated; in patients without gastric mucosal atrophy, gastric lanthanum deposition appears as diffuse white lesions in the posterior wall and lesser curvature of the gastric body. In the gastric mucosa with atrophy, lanthanum-related lesions likely appear as annular or granular whitish lesions. Moreover, these white lesions are probably more frequently observed in the lower part of the stomach, where intestinal metaplasia begins.
Core tip: This review provides an overview of the endoscopic and pathological diagnosis of gastroduodenal lanthanum deposition. Previously reported case reports, case series, and retrospective studies are reviewed, focusing on disease’s endoscopic, histological, and computed tomography features, prevalence, and outcome. Although gastroduodenal deposition presents with white appearance at esophagogastroduodenoscopy, macroscopic features and locations of gastric lesions possibly vary depending on the presence or absence of mucosal atrophy. Our hypotheses are also related to the pattern of lanthanum deposition in the gastric mucosa with/without atrophy, which will aid endoscopists to understand this disease entity.